Key points from article :
Systematizing the development of novel cell therapies can revolutionize regenerative medicine.
Plans to transform one type of adult cell to another type without going through a stem cell stage.
Will create a map of interactions between source cell and target cell using existing genomic data.
This will help to identify the differences between the two cells.
Will make predictions on how many and what interventions are needed to drive that change of state.
Will take four to seven years for getting novel cell therapies from concept to market using this.
UK-based biotech startup Mogrify, has closed an initial $16 million Series A for this project.
